BRIEF—Report on cGMP reviews during pandemic

Law firm BakerHostetler has issued a report reviewing the US Food and Drug Administration's stance on Current Good Manufacturing Practice (cGMP) regulations, in light of the COVID-19 pandemic.

The company notes that the agency has postponed most foreign facility inspections, as well as all domestic routine surveillance facility inspections.

The full alert can be viewed  here.